SomnoMed Limited (ASX:SOM)
0.6000
0.00 (0.00%)
Jun 5, 2026, 3:01 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 131.45 million as of June 5, 2026. Its market cap has increased by 35.17% in one year.
Market Cap
131.45M
Enterprise Value
120.03M
Revenue
118.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 131.45M, an increase of 273.41%. That is a compound annual growth rate of 6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 131.45M | -22.01% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 223.11M |
| EBR Systems | 171.21M |
| EMVision Medical Devices | 152.45M |
| Saluda Medical | 118.45M |
| Lumos Diagnostics Holdings | 97.01M |
| Epiminder | 82.21M |
| Cleo Diagnostics | 70.48M |
| Compumedics | 50.94M |